"In February 2024, the J U.S.-Egypt Science and Technology Joint Fund organized a study tour for eight Egyptian technology transfer professionals to the United States. They participated in AUTM's tech-transfer conference and interacted with American innovation practitioners. This activity is delivered in partnership with the AUTM and administered by the National Academy of Sciences, Engineering, and Medicine in the U.S. and by the Science, Technology, and Innovation Funding Authority (STDF) in Egypt through funding provided by the Government of the United States and Egypt."

Curious about what happens after submitting your patent application? This webinar willl demystify the post-filing process and provide insights into patent examination procedures.

Boston Scientific Corporation received FDA approval for the Farapulse™ Pulsed Field Ablation (PFA) System, a simple, cost-effective alternative to the standard-of-care thermal ablation treatment. University of Iowa startup Farapulse, Inc. (originally Iowa Approach), developed the technology before medical device corporation Boston Scientific acquired the company in June 2021. Farapulse was founded by Dr. Steven Mickelsen in the Carver College of Medicine.

Emmyon, a start-up company founded by Dr. Christopher Adams during his tenure at the University of Iowa, has announced the publication of an important new study conducted in collaboration with Virbac Corporation, an international leader in nutritional and pharmaceutical products for animal health.

Explore the resources available through the Office of the Vice President for Research to help researchers, scholars, and creators across our campus achieve their research goals.

Cardio Diagnostics Holdings, Inc. a pioneering AI-driven precision cardiovascular medicine company by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism."

Lantheus Holdings, Inc. today announced it has entered into multiple strategic agreements with Perspective Therapeutics, Inc., co-founded by UI Professor Mark Schultz and Dr. Frances Johnson, a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body.

Lyle and Sharon Bighley Chair and Professor Aliasger Salem has been named a Fellow of the National Academy of Inventors (NAI). Election as an Academy Fellow is the highest professional distinction awarded solely to inventors.

The Innovation Challenge will bring $225,000 in total funding during the 2023-24 academic year across the University of Iowa's campus. The Challenge is a university-wide competition with the goal to identify, advance and support the most innovative and entrepreneurial projects on campus.

Please join UIRF at the upcoming innovation day, October 10th, at the Stanley Hydraulics Lab. Agenda includes educational sessions on intellectual property and information for graduate students and post-docs. Lunch provided!